Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alector Inc (ALEC)

Alector Inc (ALEC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 474,214
  • Shares Outstanding, K 96,385
  • Annual Sales, $ 97,060 K
  • Annual Income, $ -130,390 K
  • 60-Month Beta 0.82
  • Price/Sales 4.89
  • Price/Cash Flow N/A
  • Price/Book 2.65
Trade ALEC with:

Options Overview Details

View History
  • Implied Volatility 173.32% ( +30.31%)
  • Historical Volatility 51.32%
  • IV Percentile 99%
  • IV Rank 79.25%
  • IV High 212.72% on 11/13/23
  • IV Low 22.88% on 08/31/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 21
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 1,913
  • Open Int (30-Day) 1,900

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.50
  • Number of Estimates 6
  • High Estimate -0.44
  • Low Estimate -0.58
  • Prior Year 0.02
  • Growth Rate Est. (year over year) -2,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.86 +1.23%
on 05/30/24
5.69 -13.53%
on 05/16/24
-0.16 (-3.15%)
since 04/30/24
3-Month
4.80 +2.50%
on 04/25/24
7.57 -35.01%
on 03/01/24
-2.05 (-29.41%)
since 02/29/24
52-Week
3.66 +34.43%
on 11/16/23
9.06 -45.73%
on 08/04/23
-2.67 (-35.18%)
since 05/26/23

Most Recent Stories

More News
Alector: Q1 Earnings Snapshot

Alector: Q1 Earnings Snapshot

ALEC : 4.92 (unch)
Alector: Q4 Earnings Snapshot

Alector: Q4 Earnings Snapshot

ALEC : 4.92 (unch)
Alector Prices New Public Offering

Alector, Inc. (NASDAQ: ALEC) shares fell back Wednesday. The San Francisco-based biotechnology company, ...

ALEC : 4.92 (unch)
Alector: Q3 Earnings Snapshot

Alector: Q3 Earnings Snapshot

ALEC : 4.92 (unch)
Alector: Q2 Earnings Snapshot

Alector: Q2 Earnings Snapshot

ALEC : 4.92 (unch)
Does Alector (ALEC) Have the Potential to Rally 86.38% as Wall Street Analysts Expect?

The consensus price target hints at an 86.4% upside potential for Alector (ALEC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...

ALEC : 4.92 (unch)
Alector (ALEC) Reports Q1 Loss, Tops Revenue Estimates

Alector (ALEC) delivered earnings and revenue surprises of 26.67% and 79.32%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ALEC : 4.92 (unch)
CLSD : 1.4000 (+0.72%)
Alector: Q1 Earnings Snapshot

Alector: Q1 Earnings Snapshot

ALEC : 4.92 (unch)
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?

Acadia (ACAD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ACAD : 15.10 (+0.67%)
ALEC : 4.92 (unch)
Are Options Traders Betting on a Big Move in Alector (ALEC) Stock?

Investors need to pay close attention to Alector (ALEC) stock based on the movements in the options market lately.

ALEC : 4.92 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco,...

See More

Key Turning Points

3rd Resistance Point 5.26
2nd Resistance Point 5.18
1st Resistance Point 5.05
Last Price 4.92
1st Support Level 4.84
2nd Support Level 4.76
3rd Support Level 4.63

See More

52-Week High 9.06
Fibonacci 61.8% 7.00
Fibonacci 50% 6.36
Fibonacci 38.2% 5.72
Last Price 4.92
52-Week Low 3.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar